Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Alcohol Research Centers (P50 Clinical trial Optional)

Active
Yes
Status
Forecasted
Estimated Post Date
April 15th, 2024
Estimated Close Date
November 15th, 2024
Estimated Award Date
November 1st, 2025
Award Ceiling
$1,150,000.00
Opportunity No.
NOT-AA-24-007

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for Specialized Alcohol Research Centers (P50 Clinical trial Optional). This grant aims to support a broad-based Alcohol Research Centers program that fosters interdisciplinary and collaborative research on Alcohol Use Disorder (AUD), alcohol misuse, alcohol-related problems, and other health-related consequences across the lifespan. The funding opportunity is expected to be published in Spring 2024, with an application due date in Fall 2024. The grant will utilize the P50 activity code.

Description

The National Institute on Alcohol Abuse and Alcoholism ( NIAAA) intends to reissue RFA-AA-23-001, �Specialized Alcohol Research Centers (P50, Clinical Trial Optional)�, �by publishing a NOFO to solicit applications for a broad-based Alcohol Research Centers program to foster and conduct interdisciplinary, collaborative research on Alcohol Use Disorder (AUD), alcohol misuse and alcohol-related� problems, and other health-related� consequences across the lifespan.� This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.� The NOFO is expected to be published in Spring 2024 with an expected application due date in Fall 2024. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Notice of Intent to Publish a Funding Opportunity Announcement for Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for Comprehensive Alcohol Research Centers (P60 Clinical trial Optional). This opportunity aims to support interdisciplinary and collaborative research on Alcohol Use Disorder (AUD), alcohol misuse, alcohol-related problems, and other health-related consequences across the lifespan. The funding will be provided through a grant, and there is no cost sharing or matching requirement. The estimated synopsis post date is April 15, 2024, with an expected application due date in Fall 2024. The estimated award date is November 1, 2025, and the estimated project start date is January 1, 2026. The maximum award ceiling is $1,250,000. Eligible applicants include organizations and institutions other than the NIH. The opportunity falls under the category of Health and is considered discretionary. The opportunity will be published in Spring 2024, and further details will be provided in the Notice of Funding Opportunity (NOFO).
Specialized Alcohol Research Centers (P50 Clinical trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Specialized Alcohol Research Centers (P50 Clinical trial Optional)". This grant is part of the Health category and falls under the discretionary funding activity. The grant does not require cost sharing or matching. The CFDA number associated with this grant is 93.273. The purpose of this grant is to invite applications for specialized Alcohol Research Centers using the P50 mechanism. These centers are intended to provide leadership in conducting interdisciplinary, collaborative research on various topics related to alcohol use disorder, alcohol-related end-organ diseases, and their consequences. The research topics may include the nature, etiology, genetics, diagnosis, treatment, and prevention of alcohol use disorder. The centers are also expected to contribute to the development of new research methods, technologies, and approaches in this field. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic (non-U.S.) entities (foreign organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. However, non-domestic (non-U.S.) entities (foreign organizations) and non-domestic components of U.S. organizations are not eligible to apply. The grant has a closing date of November 15, 2024, and the award ceiling is $1,150,000. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-007.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-007.html). For any inquiries or additional information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)". This grant is in the category of Health and falls under the funding instrument type of Grant. The purpose of this grant is to support an integrated, broad-based multidisciplinary, multi-investigator, long-term program of research and research support activities planned around a specific major research theme related to alcohol research. The grant does not require any cost sharing or matching requirement. The maximum award ceiling for this grant is $1,250,000. The eligibility for this grant is open to various types of applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, Non-domestic (non-U.S.) Entities (Foreign Organization) and non-U.S. components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. The closing date for this grant opportunity is November 15, 2024, and the archive date is December 21, 2024. For more information and to apply, please visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-008.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-008.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
Notice of Intent to Publish: Alcohol-associated Hepatitis Clinical Network � Late Phase Clinical Trials
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a notice of intent for the Alcohol-associated Hepatitis Clinical Network - Late Phase Clinical Trials. This opportunity falls under the category of Health and is a forecasted discretionary grant. The purpose of this grant is to support the continuation of clinical research sites and a Data Coordinating Center for the Alcohol-associated Hepatitis Network (AlcHepNet). AlcHepNet aims to improve biomedical, psychosocial, and quality of life outcomes for patients with advanced alcohol-associated liver disease. The grant is expected to be published in late December 2023 or early January 2024, with an application due date in late February 2023 or early March 2024. The grant will utilize the U01 and U24 grant mechanisms to support the clinical sites and Data Coordinating Center, respectively.